Home / Sweden / Elicera Therapeutics AB
Elicera Therapeutics AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
8 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
February 26, 2025 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 21, 2025 | Guevoura Fund | 1.20% | still open |
| March 10, 2025 | Guevoura Fund | 1.60% | still open |
| March 7, 2025 | Guevoura Fund | 1.57% | still open |
| March 6, 2025 | Guevoura Fund | 1.39% | still open |
| March 4, 2025 | Guevoura Fund | 1.04% | still open |
| March 3, 2025 | Guevoura Fund | 0.80% | still open |
| February 27, 2025 | Guevoura Fund | 0.61% | still open |
| February 26, 2025 | Guevoura Fund | 0.58% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Elicera Therapeutics AB, source Finansinspektionen, data as at March 21, 2025, https://www.quivad.com/action/elicera-therapeutics-ab